Interestingly, both of these studies hinted at the possible modulation of NF-κB signaling, which was earlier shown by us to be modulated by garcinol in breast, prostate, and pancreatic cancer cells [2,3]. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.